v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 152,169 $ 99,236 $ 253,175 $ 205,683
General and administrative 29,492 16,555 53,763 32,480
Total operating expenses 181,661 115,791 306,938 238,163
Loss from operations (181,661) (115,791) (306,938) (238,163)
Other income (expense):        
Interest income 7,788 6,625 16,544 13,725
Interest expense (4,595) (94) (8,797) (94)
Other expense, net (88) (1,597) (219) (1,687)
Total other income, net 3,105 4,934 7,528 11,944
Net loss $ (178,556) $ (110,857) $ (299,410) $ (226,219)
Net loss per share - basic $ (1.08) $ (0.97) $ (1.81) $ (2.02)
Net loss per share - diluted $ (1.08) $ (0.97) $ (1.81) $ (2.02)
Weighted average common shares outstanding, basic 165,451,388 113,873,126 165,240,803 111,900,818
Weighted average common shares outstanding, diluted 165,451,388 113,873,126 165,240,803 111,900,818
Comprehensive loss:        
Net Income (Loss) $ (178,556) $ (110,857) $ (299,410) $ (226,219)
Other comprehensive loss:        
Unrealized gains (losses) on marketable securities, net (216) 11 (828) 246
Comprehensive loss $ (178,772) $ (110,846) $ (300,238) $ (225,973)